(1 - 8 von 9
)
Samsung Bioepis Partners with Sandoz to CommercializeGlobeNewswire
www.globenewswire.com
AP — ” said Sang-Jin Pak, Executive Vice President and Head of Commercial Division, at Samsung Bioepis. SB17, a proposed biosimilar to Stelara AP — ” said Sang-Jin Pak, Executive Vice President and Head of Commercial Division, at Samsung Bioepis. SB17, a proposed biosimilar to Stelara ...
Samsung Bioepis and Sandoz Partner to Launch SB 히트뉴스
www.hitnews.co.kr
AP — Sang-Jin Pak, Executive Vice President and Head of the Commercial Division, remarked, "This partnership underscores our unwavering AP — Sang-Jin Pak, Executive Vice President and Head of the Commercial Division, remarked, "This partnership underscores our unwavering ...
Samsung Bioepis, Sandoz enter commercial agreement for ...Healio
www.healio.com
AP — ... Sang-Jin Pak, MD, MSc, executive vice president and head of commercial division at Samsung Bioepis, said in the release. SB17 is the AP — ... Sang-Jin Pak, MD, MSc, executive vice president and head of commercial division at Samsung Bioepis, said in the release. SB17 is the ...
Samsung Bioepis, Sandoz partner to market Ustekinumab ...NS Healthcare
www.ns-healthcare.com
AP — Samsung Bioepis Commercial Division head and executive vice president Sang-Jin Pak said: “This agreement is a testament to Samsung Bioepis AP — Samsung Bioepis Commercial Division head and executive vice president Sang-Jin Pak said: “This agreement is a testament to Samsung Bioepis ...
sortiert nach Relevanz / Datum